References
- , USA v Barr Laboratories, Inc., Civil Action 92–1744, US District Court New Jersey, Judge Alfred M. Wolin decision, February 1993
- Compounding in today's practice. Am. Pharm., NS31 1991; 10: 31–37
- , National Association of Boards of Pharmacy Model State Pharmacy Act 1.2, 1.4, Section 105 Definitions.
- , Good Compounding Practices Applicable to State Licensed Pharmacies, issued by NABP.
- , FDA Compliance Policy Guide 7132.16, Chapter 32— Drugs General
- , Correspondence to Ronald Chesemore (FDA Associate Commissioner for Regulatory Affairs), signed by John M. Hammond (Director, Practice Affairs, APhA), C. Edwin Webb (Director of Government Affairs and Health Policy, AACP), Maude Babington (Associate Executive Director, ASCP), and Charles E. Myers (Director, Professional Practice Division, ASHP), dated July 29, 1992
- , Cedars North Tower Pharmacy, Inc. v U.S., United States District Court, S.D., Florida, August 20, 1978
- , Professionals and Patients for Customized Care v Donna Shalala, et al.; Civ. A. No. H-92–1499, United States District Court, S.D., Texas, Houston Division, April 4, 1994
- , U.S. v Sene X Eleemosynary Corp, Inc., No. 79–2661-Civ-SMA, United States District Court, S.D., Florida, October 17, 1979
- , Correspondence to State Board of Pharmacy Officials, State Drug Officials, FDA Regional Food and Drug Directors, FDA District Directors, and FDA Office Directors, signed by Ronald G. Chesemore and Carmen A. Catizone (Executive Director, NABP), dated December 8, 1992